SBI Okasan Asset Management’s Bio-Techne TECH Stock Holding History

SBI Okasan Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$889K	–	341
2025 Q4	$889K	Buy	+15,000	New	+$911K	0.05%	124

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SBI Okasan Asset Management's TECH Position: Q1 2026 in Review

SBI Okasan Asset Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 15,000 shares — an estimated $889K sold.

SBI Okasan Asset Management first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $889K in Q4 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

SBI Okasan Asset Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
SBI Okasan Asset Management sold 15,000 Bio-Techne shares in Q1 2026, an estimated $889K.
SBI Okasan Asset Management first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
SBI Okasan Asset Management's Bio-Techne position peaked at $889K in Q4 2025.
585 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on SBI Okasan Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.